The American Joint Committee on Cancer (AJCC) staging system is inadequate for an accurate prognosis in nasopharyngeal carcinoma (NPC). Thus, new biomarkers are under intense investigation. Here, we investigated whether the density of TILs could predict prognosis in NPC. First, we used 1490 cases of nasopharyngeal carcinoma samples from two independent cohorts to evaluate the density and distribution of tumor-infiltrating lymphocytes (TILs). Second, in one cohort, we assessed associations between TILs and clinical outcomes in 593 randomly selected samples (defined as the training set) and validated findings in the remaining 593 samples (defined as the validation set). Furthermore, we confirmed the prognostic value of TILs in a second independent cohort of 304 cases (defined as the independent set). Based on multivariable Cox regression analysis, we also established an effective prognostic nomogram including TILs to improve accuracy in predicting disease-free survival (DFS) for patients with nondisseminated NPC. We found that high TILs in the training set were significantly associated with favorable DFS [hazard ratio (HR) 0.41, 95% confidence interval (CI) 0.28-0.58, p < 0.001], overall survival (OS, HR 0.42, 95% CI 0.27-0.64, p < 0.001), distant metastasis-free survival (DMFS, HR 0.37, 95% CI 0.23-0.58, p < 0.001) and local-regional recurrent free survival (LRRFS, HR 0.43, 95% CI 0.25-0.73, p 5 0.002). Multivariate analysis showed that TILs are an independent prognostic indicator for DFS in all cohorts. In summary, this study indicated that TILs may reflect the immunological heterogeneity of NPC and could represent a new prognostic biomarker.
standard of care for locoregionally advanced NPC. However, large variations in the clinical outcomes have been reported in patients with the same stage of cancer who were recipients of similar treatment strategies. 3 These findings suggest that the present anatomical information based on staging system is insufficient to obtain an accurate and defined prognosis. Thus, new biomarkers which can reflect the biological and immunological heterogeneity of NPC, provide additional value to prognostic predictions and further facilitate more precise therapies for this disease are urgently demanded.
Some recent studies have reported that the specific immunological status can contribute to tumor progression, and it is associated with the clinico-pathological characteristics and prognosis of patients. 4, 5 In addition, many studies have demonstrated that nonmalignant tumor-infiltrating lymphocytes (TILs) infiltrate into the tumor and stroma, 6, 7 which play an important role in the tumor microenvironment. Furthermore, TILs are considered as a convenient stratification factor that can systematically evaluate cancer-associated immunologic function of the patient. Data from many studies addressing various types of cancers (breast, 6, 8 lung, 9 melanoma, 7 laryngeal 10 and gastric cancer 11 ) have shown that the presence of higher quantities of TILs are associated with significantly better prognosis. Moreover, TILs have been shown to predict response to neoadjuvant chemotherapy in breast cancer. 8 NPC tumor biopsies are histopathologically characterized by an abundant infiltration of nonmalignant lymphocytes. 12 However, there is a dearth of information regarding the prognostic value of TILs in NPC.
In this study, we aimed to investigate the prognostic value of Intratumoral Lymphocyte Infiltrating Intensity (I-TLII), Stromal Lymphocyte Infiltrating Intensity (S-TLII) and total intensity of TILs in a large and relatively homogeneous group of NPC patients who underwent radiotherapy, with or without chemotherapy.
Materials and Methods

Patients and pathology materials
Hematoxylin and eosin (H&E) slides for 1186 patients were collected from the Department of Pathology, Sun Yat-sen University Cancer Centre, (Guangzhou, China) between January 2006 and December 2013. Additionally, H&E slides from 304 patients were derived from the Affiliated Hospital of Guilin Medical University between January 2008 and June 2014. All Patients in this study were nonkeratinizing undifferentiated NPC patients. None of the NPC patients received radiotherapy or chemotherapy treatment before biopsy. All patients with newly diagnosed, nondisseminated and histologically proven NPC were treated with radiotherapy and 1276 (85.6%) of 1490 patients also received platinum-based chemotherapy. The patients were manually restaged according to the eighth American Joint Committee on Cancer TNM staging. 13 This study was approved by the 15 Both I-TLII and S-TLII are continuous parameters. I-TLII and S-TLII were both independently evaluated by two pathologists who were blinded to clinical information, including treatment allocation and outcomes. The discordant cases were reviewed until a final consensus classification was obtained. TILs were evaluated by combining I-TLII and S-TLII. As this study was the first of its kind to evaluate the prognostic value of TILs in NPC, a specific TIL cutoff was not prespecified. The Recursive Partitioning Analysis and Regression Trees (RPART) approach was adopted to determine optimal cutoff values of high and low expression of I-TLII and S-TLII with respect to disease-free survival (DFS) in the What's new? Doctors typically use tumor stage to help determine cancer prognosis, but for nasopharyngeal cancer, it is not precise enough. These authors turned to the immune system for prognostic clues. They looked at the density and distribution of tumorinfiltrating lymphocytes (TILs) in NPC patients from China. TILs turned out to be a strong independent predictor of disease-free survival: greater numbers of TILs, they found, meant better outcomes. Once a standardized method for evaluating TILs can be developed, this metric could be extremely valuable for predicting disease progression in NPC patients.
training set. RPART can objectively divide samples at each step into two subgroups for the object variable, which provides maximum discrimination and yields subgroups with a relatively homogeneous performance. 16 Based on RPART, we used a cutoff value of 10% for I-TLII and 70% for S-TLII. Furthermore, we defined subgroups with a cutoff value based on the percentage of intratumoral TILs and stromal TILs (high-TILs: I-TLII > 10% and/or S-TLII > 70% vs. low-TILs: I-TLII 10% and S-TLII 70%).
Statistical analyses
DFS was selected as our primary outcome. Secondary outcomes included overall survival (OS), distant metastasis-free survival (DMFS) and local-regional recurrent-free survival (LRRFS). We calculated DFS to the date of the first relapse at any site or death from any cause (whichever occurred first), OS from treatment to death from any cause, DMFS to the first distant relapse and LRRFS was defined as the appearance of a newly detected local-regional recurrence. All cases were confirmed by nasopharyngeal biopsy or two radiologic images with or without elevation of tumor biomarkers. A cutoff level of 4,000 copies/mL was used to define low and high pretreatment EBV DNA levels. [17] [18] [19] The association between TILs and clinico-pathological variables were calculated using v 2 tests with continuity correction. The Spearman method was used to calculate the correlation between I-TLII and S-TLII. Survival was estimated using the Kaplan-Meier method and differences were compared using the log-rank test. Univariate and multivariate analysis using a Cox proportional hazards model was used to test the independent significance of different factors by backward elimination. Since TILs were evaluated by combining I-TLII and S-TLII, I-TLII and S-TLII were not included in the multivariate analysis. Other significant variables (p 0.1) were included in the multivariate analysis and only independent prognostic factors were retained in the multivariate model, 20 which make the model more stable. Nomograms were formulated based on the results of multivariable Cox regression analysis. The accuracy of the nomogram was evaluated by the concordance index (Cindex) and assessed by comparing nomogram-predicted probability vs. actual overall survival probability. A larger C-index indicated more accurate prognostic stratification. Bootstraps with 1,000 resamples were applied to these activities.
All statistical tests were two sided, and considered significant when p < 0.05. Statistical analyses were performed using Statistical Package for the Social Sciences (SPSS) version 22.0 (IBM, Armonk, NY, USA) and R software (R version 3.2.3; rms package, "rpart" package version4.1-10, http://www.rproject.org/). All study data have been retained at Sun Yatsen University Cancer Centre for future reference (number RDDB2017000079).
Results
Distribution and association of TILs with clinico-pathologic characteristics
Overall, there were 1490 eligible patients for the study. 1186 patients from Sun Yat-sen University Cancer Centre were available for I-TLII, in which 1175 patients with available S-TLII evaluation. We could not perform a correct S-TLII estimation in 11 cases because of staining decolouration and tissue artifacts. For the patients from the Affiliated Hospital of Guilin Medical University, all 304 patients were available for I-TLII and S-TLII. Lymphocytic infiltration was observed in the majority of H&E slides, but the number of lymphocytes in the stroma were significantly greater compared with intratumoral sites. A significant correlation was observed between I-TLII and S-TLII (Spearman correlation coefficient 0.244, p < 0.001) in the training set. The significance persisted in the validation set (Spearman correlation coefficient 0.274, p < 0.001) and independent set (Spearman correlation coefficient 0.20, p < 0.001). RPART was used to determine optimal cut-off values of high and low expression of I-TLII and S-TLII in the training set with respect to DFS. By combining I-TLII and S-TLII, TILs were used to divide patients into different subgroups, which allowed evaluation of their utility as a prognostic marker. In the training set, 292 patients were defined as having high-TILs, and 299 patients as having lowTILs. The number of patients with high-TILs or low-TILs in the validation set and independent set are presented in Table  1 . The histopathologic examples of lymphocytic infiltration are shown in Figure 1 . Table 1 shows the relationship between clinico-pathologic characteristics and TILs in the training set, validation set, and independent set. In all sets, age and T stage were inversely and significantly associated with TILs. Comparing to patients with low levels of TILs, more patients with high levels of TILs tended to be younger. This is likely due to stronger immune system of young patients. There was also a significant inverse association between TILs and T stage (p < 0.05, Table 1 ) in all sets.
Association of TILs with prognosis
Median follow-up duration for patients from Sun Yat-sen University Cancer Centre with assessable TILs was 58 months (IQR 43 2 66) for disease-free survival (DFS) and 268 DFS events occurred. For patients from the Affiliated Hospital of Guilin Medical University, the median follow-up duration was 50 months (IQR 36-62) for DFS and 71 DFS events occurred. In all sets, TILs were inversely and significantly associated with DFS (p < 0.05, Figs. 2a, 2e and 2i). The Kaplan-Meier survival curves for the training cohort showed that the high-TILs group had a higher percentage of DFS than the low-TILs group, with 87.4% 5-year DFS in the high-TILs group compared with 67.8% 5-year DFS in the low-TILs group (HR 0.41, 95% CI 0.28-0.58, log-rank p < 0.001, Fig. 2a) . Similar results were observed in the validation set (87.0% vs. 72.4%, HR 0.52, 95%CI 0.36-0.75, log-rank p < 0.001, Fig. 2e ) and independent set (82.4% vs. 71.8%, HR 0.54, 95%CI 0.33-0.86, log-rank p < 0.011, Fig.  2i ). In the training and validation set, TILs were also significantly correlated with OS, DMFS and LRRFS in the univariate analysis (Fig. 2 and Supporting Information, Table  S1 ). When patients were stratified by I-TLII, the difference in DFS, OS and DMFS was also significant in the training and validation set (Supporting Information, Figs. S1a-S1c and S1e-S1g). However, in the independent set, we did not find a Table S1 and Figs. S2e-S2g, S2i and S2j). Multivariate analysis showed that the value of TILs was an independent prognostic factor for DFS in the training and validation sets (Table 2 ). In addition to TILs, T stage, N stage, radiotherapy technique and EBV DNA were also significantly associated with DFS in the training and validation set in the multivariate analysis ( Table 2) . As EBV DNA load, VCA-IgA, EA-IgA and hs-CRP were not tested at the Affiliated Hospital of Guilin Medical University before 2015, these factors were not included in the multivariate analysis. TILs, T stage, radiotherapy technique and LDH were associated with DFS in the independent set ( Table 2 ). Factors that were associated with OS in univariate and multivariate analyses were shown in Supporting Information Tables S2 and S3. Age was also an independent prognostic factor for OS in the validation and independent set.
Establishment and validation of a nomogram with TILs
To develop an applicable model for prediction of individual 3-year and 5-year disease-free survival probability, we composed a nomogram (Fig. 3 ) using the variables of T stage, N stage, radiotherapy technique and TILs, which were all independent factors derived from multivariable analysis of the training set. In the cohort, the Harrell's concordance index (C-index) for the nomogram to predict DFS was estimated to be 0.699 in the training set, 0.667 in the validation set, and 0.702 in the independent set. In Figure 4 , the x-axes illustrate predicted DFS calculated by the nomogram and the y-axes indicate observed actual DFS, while the solid lines represent the ideal reference line for which predicted DFS corresponds with actual DFS. Reassuringly, the calibration plot for the probability of 3-year or 5-year DFS after treatment showed optimal agreement between the prediction by nomogram and actual observation for nomogram in all sets (Figs. 4a-4f) . As EBV DNA load was also a strong predictor of DFS for NPC patients, we also developed a new nomogram using the variables of T stage, N stage, radiotherapy, TILs and EBV DNA Fig. 3a) . The C-index was 0.715 in the training set and 0.683 in the validation set.
Discussion
We have demonstrated that TILs are a powerfully independent predictor of DFS, OS, DMFS and LRRFS in patients with previously untreated NPC. Furthermore, the prognostic value of Intratumoral Lymphocyte Infiltrating Intensity (I-TLII) and Stromal Lymphocyte Infiltrating Intensity (S-TLII) has been evaluated in this study concomitantly. Our research demonstrated that S-TLII was found to be a superior parameter with a high reproducibility than I-TLII. The limited number and restricted range of intratumoral TILs might be an explanation for the inferior prognostic value of I-TLII; I-TLII are more heterogeneous and are relatively difficult to observe on H&E-stained slides. As the combination of I-TLII and S-TLII, TILs seem to be the strongest survival predictor of NPC outcomes. We believe that the results of this study provide the first and largest dataset that assesses and validates the prognostic significance of TILs using criteria described by the International ImmunoOncology Biomarker Working Group with H&E slides in primary NPC.
NPC tumors are characterized by a heavy infiltration of nonmalignant lymphocytes and have even been termed as "lymphoepithelioma." 21 Recently, data from many studies of various types of cancers have shown associations between high quantities of TILs and significantly favorable prognosis. 6, 7, 9 However, the prognostic value of TILs in NPC has not been robustly determined, although some studies have reported associations between lymphocytes and overall survival or disease-free survival in NPC. 5, 21 Those studies have included small numbers of patients, limited statistical power, and did not reach a consensus on how lymphocyte infiltration could influence tumor progress and prognosis. Besides, they only focused on a set of phenotypic subtypes of immune cells (including CD41, CD81, CD20, regulatory T cells and macrophages). Tumor Markers and Signatures CD8 1 TILs correlated with better DFS in early stage cancer patients, while no significant association was found between IL-171 TIL and clinico-pathological characteristics or survival in NPC patients. 5 The tumor immune microenvironment is extremely complicated with a varying abundance of infiltrating cell types. It would certainly be desirable to obtaining a more detailed picture of the different immune cells involved to actually understand the immune systemtumor interaction. Besides, global TILs can be used to systematically evaluate the patients' anticancer immunological function, therefore they might possibly be a valuable prognostic factors. In this study, we found that the higher TIL quantities was significantly associated with better DFS, OS, DMFS and LRRFS in NPC patients. We believe that TILs could act as a valuable immunological parameter in predicting prognosis in NPC patients. Emerging evidence indicated that TILs may predict responses to immunotherapies, including CTLA-4 and PD-1/ PD-L1 antibodies, 24, 25 thus a further understanding of TILs was of great importance. Furthermore, TILs from NPC biopsy specimens have been reported to be cultured ex vivo and used as a T-cell-based immunotherapy for NPC patients. 26 A phase I immunotherapy trial of adoptively transferred TILs has been performed on 23 NPC patients with locoregionally advanced NPC following concurrent chemoradiotherapy. This study demonstrated that NPC patients can tolerate adoptive cell therapy with TILs following CCRT and experience sustained antitumor activity and anti-EBV immune responses. 27 Additionally, a larger phase II trial is in progress. Although TILs have shown some therapeutic effect, its prognostic effect has been overlooked. Our study emphasized that TILs are a powerful, independent predictor of DFS in NPC patients and deserve further investigation.
Nomograms are graphical depictions of predictive statistical models for individual patients, and they have been widely developed for different types of cancers. 28, 29 Nomograms can integrate various independent prognostic factors; therefore, their ability to predict patient outcomes is that they have an advantage over the traditional staging systems used for many cancers. Based on our results, TILs are the strongest independent predictor of DFS. Thus, the nomogram that we have developed to predict DFS incorporating TILs and other independent prognostic factors could estimate individual risks and serve as a valuable decision-making tool for cancer clinicians.
Several limitations should be noted in presenting our findings. First, there is currently no consensus for evaluating TILs in NPC. Thus, the method for interpreting TILs and the appropriate cutoff values need to be standardized. Second, although we have analyzed a large cohort and validated it with an independent cohort, all patients in this study were retrospectively enrolled from China (where NPC is highly prevalent). Therefore, further additional sets of independent samples from non-Asian patients are required to confirm our findings.
In summary, this study demonstrated that the majority of NPC samples have TILs either in the tumor or stroma. Furthermore, we also demonstrated that TILs are a strong and independent prognostic factor for NPC patients. In addition, we presented a nomogram comprising TILs that may help predict risk of individual disease progress and could be potentially useful for NPC precision medicine. We firmly believed that TIL grade deserves further prospective investigation to determine its prognostic value and to assess whether it should be routinely included in primary NPC pathology reports. Besides, as a prerequisite, a standardized Tumor Markers and Signatures methodology for evaluating TILs is needed so as to integrate this parameter in a standard histopathological practice, in a research setting as well as in clinical trials.
